| Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia Cancer Genome Atlas Research Network New England Journal of Medicine 368 (22), 2059-2074, 2013 | 4617 | 2013 |
| Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy S Giralt, E Estey, M Albitar, K Van Besien, G Rondón, P Anderlini, ... Blood, The Journal of the American Society of Hematology 89 (12), 4531-4536, 1997 | 1490 | 1997 |
| Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia KG Roberts, Y Li, D Payne-Turner, RC Harvey, YL Yang, D Pei, ... New England journal of medicine 371 (11), 1005-1015, 2014 | 1473 | 2014 |
| Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias I Tamm, SM Kornblau, H Segall, S Krajewski, K Welsh, S Kitada, ... Clinical Cancer Research 6 (5), 1796-1803, 2000 | 972 | 2000 |
| MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia R Garzon, S Volinia, CG Liu, C Fernandez-Cymering, T Palumbo, ... Blood, The Journal of the American Society of Hematology 111 (6), 3183-3189, 2008 | 818 | 2008 |
| Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells R Tibes, YH Qiu, Y Lu, B Hennessy, M Andreeff, GB Mills, SM Kornblau Molecular cancer therapeutics 5 (10), 2512-2521, 2006 | 753 | 2006 |
| Recommended guidelines for the treatment of cancer treatment-induced diarrhea AB Benson III, JA Ajani, RB Catalano, C Engelking, SM Kornblau, ... Journal of Clinical Oncology 22 (14), 2918-2926, 2004 | 741 | 2004 |
| Treatment of Philadelphia chromosome–positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate DA Thomas, S Faderl, J Cortes, S O'Brien, FJ Giles, SM Kornblau, ... Blood 103 (12), 4396-4407, 2004 | 733 | 2004 |
| Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell … S Giralt, PF Thall, I Khouri, X Wang, I Braunschweig, C Ippolitti, D Claxton, ... Blood, The Journal of the American Society of Hematology 97 (3), 631-637, 2001 | 704 | 2001 |
| MicroRNA 29b functions in acute myeloid leukemia R Garzon, CEA Heaphy, V Havelange, M Fabbri, S Volinia, T Tsao, ... Blood, The Journal of the American Society of Hematology 114 (26), 5331-5341, 2009 | 558 | 2009 |
| Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML CD DiNardo, IS Tiong, A Quaglieri, S MacRaild, S Loghavi, FC Brown, ... Blood, The Journal of the American Society of Hematology 135 (11), 791-803, 2020 | 466 | 2020 |
| PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia Z Gu, ML Churchman, KG Roberts, I Moore, X Zhou, J Nakitandwe, ... Nature genetics 51 (2), 296-307, 2019 | 458 | 2019 |
| Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia M Milella, SM Kornblau, Z Estrov, BZ Carter, H Lapillonne, D Harris, ... The Journal of clinical investigation 108 (6), 851-859, 2001 | 452 | 2001 |
| Efficacy, safety, and biomarkers of response to azacitidine and nivolumab in relapsed/refractory acute myeloid leukemia: a nonrandomized, open-label, phase II study N Daver, G Garcia-Manero, S Basu, PC Boddu, M Alfayez, JE Cortes, ... Cancer discovery 9 (3), 370-383, 2019 | 449 | 2019 |
| Treatment of adult T-cell leukemia–lymphoma with a combination of interferon alfa and zidovudine PS Gill, W Harrington Jr, MH Kaplan, RC Ribeiro, JM Bennett, ... New England Journal of Medicine 332 (26), 1744-1748, 1995 | 437 | 1995 |
| High frequency and poor outcome of Philadelphia chromosome–like acute lymphoblastic leukemia in adults KG Roberts, Z Gu, D Payne-Turner, K McCastlain, RC Harvey, IM Chen, ... Journal of Clinical Oncology 35 (4), 394, 2017 | 424 | 2017 |
| Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults N Jain, KG Roberts, E Jabbour, K Patel, AK Eterovic, K Chen, ... Blood, The Journal of the American Society of Hematology 129 (5), 572-581, 2017 | 367 | 2017 |
| BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia MS Zabriskie, CA Eide, SK Tantravahi, NA Vellore, J Estrada, FE Nicolini, ... Cancer cell 26 (3), 428-442, 2014 | 344 | 2014 |
| Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or … E Estey, P Thall, M Andreeff, M Beran, H Kantarjian, S O'Brien, S Escudier, ... Journal of Clinical Oncology 12 (4), 671-678, 1994 | 329 | 1994 |
| The public repository of xenografts enables discovery and randomized phase II-like trials in mice EC Townsend, MA Murakami, A Christodoulou, AL Christie, J Köster, ... Cancer cell 29 (4), 574-586, 2016 | 328 | 2016 |
Kevin CoombesProfessor of Population Health Sciences, Georgia Cancer Center at Augusta UniversityGeverifieerd e-mailadres voor augusta.edu
